Example: dental hygienist
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
8.4 Pediatric Use 8.5 Geriatric Use 8.6 Hepatic Impairment 8.7 Renal Impairment 8.8 Race/Ethnicity 11 DESCRIPTION ... ENTEREG is not recommended for use inthese patients. 6 ADVERSE REACTIONS ... (proton pump inhibitors (PPIs), histamine-2 ...
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Proposed Prescribing Information (USPI) Singulair
www.merck.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Asthma SINGULAIR® is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12months of age and older.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.merck.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEYTRUDAsafely and effectively. See full prescribing
M-M-R II (MEASLES, MUMPS, and RUBELLA VIRUS …
www.merck.com1 M-M-R®II (MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE) DESCRIPTION M-M-R®II (Measles, Mumps, and Rubella Virus Vaccine Live) is a live virus vaccine for vaccination ...
Medication Guide JANUMET - Merck.com
www.merck.comMedication Guide JANUMET®XR (JAN-you-met XR) (sitagliptin and metformin hydrochloride extended-release) Tablets Read this Medication Guide carefully before you start taking JANUMETXR and each time you get a refill.
Medication Guide - Merck.com
www.merck.com1 Medication Guide JANUVIA® (jah-NEW-vee-ah) (sitagliptin) Tablets Read this Medication Guide carefully before you start taking JANUVIA and each time you get a …
Patient Information EMEND (EE mend) (aprepitant) …
www.merck.comPatient Information EMEND® (EE mend) (aprepitant) capsules EMEND® (EE mend) (aprepitant) for oral suspension Read this Patient Information before you start taking EMEND and each time you get a refill.
FDA-Approved Patient Labeling - Merck.com
www.merck.com1 FDA-Approved Patient Labeling NEXPLANON (etonogestrel implant) Radiopaque Subdermal Use Only NEXPLANON does not protect against HIV infection (the virus that causes AIDS) or other sexually transmitted diseases.
For injection: 100 mg of lyophilized infliximab-abda …
www.merck.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RENFLEXIS safely and effectively. See full prescribing information …
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.merck.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively. See full prescribing
GARDASIL9 - Merck & Co.
www.merck.com1 Patient Information about GARDASIL®9 (pronounced “gard-Ah-sill nīn”) (Human Papillomavirus 9-valent Vaccine,Recombinant) Read this information with care before getting GARDASIL®9.
Related documents
Proton Pump Inhibitors: Use in Pediatric Patients
www.cms.gov2 Proton Pump Inhibitors: Use in Pediatric Patients. FDA-Approved Indications for Proton Pump Inhibitors in Pediatric Patients. Medications in the PPI drug therapy class have been proven safe and effective in children and adolescents for . the short-term treatment of GERD and EE. However, PPIs are often used to treat conditions that have not been
CELLCEPT Prescribing Information - Genentech
www.gene.comproton pump inhibitors, drugs that interfere with enterohepatic recirculation, telmisartan, calcium-free phosphate binders. ... · Pediatric Use: Safety and effectiveness in allogenic heart or liver ... suspension for pediatric kidney transplant patients 3 months and older is 600 mg/m2, ...
Perioperative Medication Management - Adult/Pediatric ...
www.uwhealth.orgJul 27, 2020 · 1.2 Proton pump inhibitors: dexlansoprazole, esomeprazole, lansoprazole, omeprazole, omeprazole/sodium bicarbonate, pantoprazole, rabeprazole 1.2.1 Parathyroid surgery 1.2.1.1 Recommend to hold proton pump inhibitors 7 days prior to and day of surgery and post-operatively until directed to resume by surgeon. (UW Health strong
Dose Conversion Chart for PPIs for IV Administration
www.clevelandclinicmeded.comthe Cleveland Clinic Hospitals have made a change in the automatic therapeutic interchange for the proton pump inhibitors (PPIs). As of January 3, 2006, the PPI on the Cleveland Clinic Formulary for adult patients who do not require a suspension is esomeprazole (Nexium®). All new medication orders for PPIs (e.g., lansoprazole, omeprazole ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.talicia.comTALICIA is contraindicated in patients with known hypersensitivity to the components of TALICIA: amoxicillin [or other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins)], omeprazole (or other benzimidazoles [e.g. proton pump inhibitors (PPIs) and anthelmintics]), rifabutin (or any other rifamycins), or
HIGHLIGHTS OF PRESCRIBING INFORMATION ——— …
www.novo-pi.com• For pediatric patients requiring less than 5 units of TRESIBA ® each day, use a TRESIBA U-100 vial (2.1). • In adults, inject subcutaneously once daily at any time of day (2.2). • In pediatric patients inject subcutaneously once daily at the same time every day (2.2). • Individualize dose based on type of diabetes, metabolic
CALQUENCE PRESCRIBING INFORMATION
den8dhaj6zs0e.cloudfront.netTable 1: Recommended Dose Modifications for Use with CYP3A Inhibitors or Inducers CYP3A Co-administered Drug Recommended CALQUENCE use Inhibition Strong CYP3A inhibitor Avoid concomitant use. If these inhibitors will be used short-term (such as anti-infectives for up to seven days), interrupt CALQUENCE. Moderate CYP3A inhibitor 100 mg once daily.